You are viewing an incomplete version of our website. Please click to reload the website as full version.

anti-Tumor Necrosis Factor Receptor Superfamily, Member 8 (TNFRSF8) Antibodies

The protein encoded by TNFRSF8 is a member of the TNF-receptor superfamily. Additionally we are shipping TNFRSF8 Kits (27) and TNFRSF8 Proteins (21) and many more products for this protein.

list all antibodies Gene Name GeneID UniProt
TNFRSF8 21941 Q60846
TNFRSF8 943 P28908
TNFRSF8 25069 P97525
How to order from antibodies-online
  • +1 877 302 8632
  • +1 888 205 9894 (toll-free)
  • Order online
  • orders@antibodies-online.com

Top anti-TNFRSF8 Antibodies at antibodies-online.com

Showing 10 out of 571 products:

Catalog No. Reactivity Host Conjugate Application Images Quantity Supplier Delivery Price Details
Mouse Hamster FITC FACS 0.5 mg Log in to see 6 to 8 Days
$379.50
Details
Human Mouse Un-conjugated EIA, FACS, IHC (fro), IHC (p), IP, WB   0.1 mg Log in to see 6 to 8 Days
$423.50
Details
Human Mouse Un-conjugated FACS, IHC (p) Human Thymus (formalin-fixed, paraffin-embedded) stained with TNFRSF8 antibody LS-B1865 at 5 ug/ml followed by biotinylated anti-mouse IgG secondary antibody LS-D2, alkaline phosphatase-streptavidin and chromogen. 0.1 mg Log in to see 4 to 5 Days
$242.55
Details
Human Mouse FITC FACS 50 μg Log in to see 6 to 8 Days
$346.50
Details
Human Mouse Un-conjugated FACS, ELISA, WB Figure 1: Red: Control Antigen (100 ng), Purple: Antigen (10ng), Green: Antigen (50 ng), Blue: Antigen (100 ng) Figure 2: Flow cytometric analysis of Hela cells using CD30 mouse mAb (green) and negative control (red) . 100 μL Log in to see 3 to 4 Days
$430.10
Details
Mouse Rat PE FACS   100 Tests Log in to see 6 to 8 Days
$313.50
Details
Mouse Hamster Biotin FACS   0.5 mg Log in to see 6 to 8 Days
$379.50
Details
Mouse Hamster PE FACS   0.1 mg Log in to see 6 to 8 Days
$308.00
Details
Mouse Rat FITC FACS   0.1 mg Log in to see 6 to 8 Days
$324.50
Details
Human Mouse Un-conjugated FACS, IHC (p), IP, WB 0.1 mg Log in to see 6 to 8 Days
$346.50
Details

TNFRSF8 Antibodies by Reactivity, Application, Clonality and Conjugate

Attributes Applications Host Clonality Conjugate
Mouse (Murine) , , , ,
, , ,
,
, , , , , , , , , , , , ,
Human , , , ,
, ,
,
, , , , , , , , , , , , , ,
Rat (Rattus) , ,


, , , , , , , , , , ,

Top referenced anti-TNFRSF8 Antibodies

  1. Human Monoclonal TNFRSF8 Primary Antibody for FACS, IHC (p) - ABIN94067 : Pavlov, Martins, Delgado: Development and validation of a fluorescent microsphere immunoassay for soluble CD30 testing. in Clinical and vaccine immunology : CVI 2009 (PubMed)
    Show all 7 references for ABIN94067

  2. Mouse (Murine) Monoclonal TNFRSF8 Primary Antibody for FACS - ABIN370914 : Bowen, Lee, Miragliotta, Nam, Podack: Structure and expression of murine CD30 and its role in cytokine production. in Journal of immunology (Baltimore, Md. : 1950) 1996 (PubMed)
    Show all 3 references for ABIN370914

  3. Mouse (Murine) Monoclonal TNFRSF8 Primary Antibody for FACS - ABIN370918 : Falini, Pileri, Pizzolo, Dürkop, Flenghi, Stirpe, Martelli, Stein: CD30 (Ki-1) molecule: a new cytokine receptor of the tumor necrosis factor receptor superfamily as a tool for diagnosis and immunotherapy. in Blood 1995 (PubMed)
    Show all 3 references for ABIN370918

  4. Mouse (Murine) Monoclonal TNFRSF8 Primary Antibody for FACS - ABIN370913 : Shanebeck, Maliszewski, Kennedy, Picha, Smith, Goodwin, Grabstein: Regulation of murine B cell growth and differentiation by CD30 ligand. in European journal of immunology 1995 (PubMed)
    Show all 3 references for ABIN370913

  5. Human Monoclonal TNFRSF8 Primary Antibody for EIA, FACS - ABIN118590 : Dürkop, Latza, Hummel, Eitelbach, Seed, Stein: Molecular cloning and expression of a new member of the nerve growth factor receptor family that is characteristic for Hodgkin's disease. in Cell 1992 (PubMed)
    Show all 2 references for ABIN118590

  6. Human Monoclonal TNFRSF8 Primary Antibody for FACS, ELISA - ABIN969019 : Kamali, Abbasi, Farokhi, Abbasi, Fallah, Seifee, Ghadimi, Rezaie: Posttransplant soluble CD30 as a predictor of acute renal allograft rejection. in Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation 2010 (PubMed)

More Antibodies against TNFRSF8 Interaction Partners

Mouse (Murine) Tumor Necrosis Factor Receptor Superfamily, Member 8 (TNFRSF8) interaction partners

  1. This study demonstrated the amelioration of MOG35-55 peptide-induced active EAE in CD30 KO mice. CD30 was expressed limitedly on CD4 (show CD4 Antibodies) T cells at the induction phase of experimental autoimmune encephalomyelitis.

  2. Data indicate that CD30L (show TNFSF8 Antibodies)/CD30 axis plays a modulatory role in the pathogenesis of experimental autoimmune encephalomyelitis (EAE).

  3. role in the maintenance and activation of IL-17A (show IL17A Antibodies)-producing gammadelta T cells

  4. These results suggest that CD30 signaling plays an important role in the activation of IL-17A (show IL17A Antibodies)-producing Vgamma1(-) Vgamma4(-) gammadelta T cells bearing Vgamma6 at an early stage of BCG (show SLC11A1 Antibodies) infection.

  5. Interference of the CD30-CD30L (show TNFSF8 Antibodies) pathway reduces atherosclerosis development.

  6. CD30L (show TNFSF8 Antibodies)/CD30 pathway acts as an accelerator of enteritis in a murine disease model

  7. role of CD30L (show TNFSF8 Antibodies)/CD30 interactions in allergic rhinitis; results suggest that CD30L (show TNFSF8 Antibodies) plays an important role in allergic rhinitis

  8. Abrogation of CD30 and OX40 (show TNFRSF4 Antibodies) signals prevents autoimmune disease in FoxP3 (show FOXP3 Antibodies)-deficient mice.

  9. Studies demonstrate that CD30L (show TNFSF8 Antibodies)/CD30 signaling executed by the T-T cell interaction plays a critical role in Th17 cell differentiation.

  10. CD30 can signal in a completely TCR-independent fashion to induce IL-13 (show IL13 Antibodies) production by effector T cells.

Human Tumor Necrosis Factor Receptor Superfamily, Member 8 (TNFRSF8) interaction partners

  1. this review is focused on the role of CD30 receptor and p53 (show TP53 Antibodies) as novel targets for therapy in ALK (show ALK Antibodies)+ ALCL, and also provides an update on their potential involvement in ALK (show ALK Antibodies)+ ALCL pathogenesis

  2. Most angioimmunoblastic T-cell lymphoma and peripheral T-cell lymphoma-not otherwise specified express variable levels of CD30.

  3. Upregulated expression of CD30 is commonly found in sclerosing angiomatoid nodular transformation of the spleen.

  4. Our results demonstrated significantly elevated sCD30 levels in AS patients compared to healthy controls (HCs (show HLCS Antibodies)) with mean values of 32.0 +/- 12.2 and 24.9 +/- 8.0 ng/mL, (P(**) = 0.007), suggesting a p role of sCD30 in the pathogenesis of AS.

  5. With the introduction of the immunoconjugate brentuximab vedotin, the CD30 antigen has become an effectively targetable molecule. Therefore, we investigated the frequency and level of CD30 expression in post-transplant lymphoproliferative disorders.

  6. Data susggest that CD30 antigen may be useful as a prognostic factor and therapeutic target in extranodal natural killer/T-cell lymphoma (NKTCL).

  7. Data indicate that CD30 antigen downregulation and P-Glycoprotein (MDR1 (show TBC1D9 Antibodies)) upregulation are associated with drug resistance to brentuximab vedotin.

  8. Intralymphatic variant of ALCL and LyP (show PTPN22 Antibodies) may be explained, at least in part, by a particular lymphotropism of the neoplastic cells of cutaneous CD30 lymphoproliferative disorders.

  9. BAG-3 (show BAG3 Antibodies) expression correlated with increased HSP70 (show HSP70 Antibodies) expression in a subset of systemic T cell lymphoma cases co-expressing the CD30 antigen.

  10. Single threonine residue at position 61 in CD30v that is critical for TRAF2 interaction, NFkappaB activation, and downstream CD30-NFkappaB-dependent phenotypes in hESCs was identified.

TNFRSF8 Antigen Profile

Protein Summary

The protein encoded by this gene is a member of the TNF-receptor superfamily. This receptor is expressed by activated, but not by resting, T and B cells. TRAF2 and TRAF5 can interact with this receptor, and mediate the signal transduction that leads to the activation of NF-kappaB. This receptor is a positive regulator of apoptosis, and also has been shown to limit the proliferative potential of autoreactive CD8 effector T cells and protect the body against autoimmunity. Two alternatively spliced transcript variants of this gene encoding distinct isoforms have been reported.

Gene names and symbols associated with TNFRSF8

  • tumor necrosis factor receptor superfamily, member 8 (TNFRSF8) antibody
  • tumor necrosis factor (ligand) superfamily, member 8 (TNFSF8) antibody
  • tumor necrosis factor receptor superfamily, member 8 (Tnfrsf8) antibody
  • Cd30 antibody
  • D1S166E antibody
  • Ki antibody
  • Ki-1 antibody
  • TNFRSF8 antibody

Protein level used designations for TNFRSF8

tumor necrosis factor receptor superfamily member 8 , tumor necrosis factor receptor superfamily, member 8 , tumor necrosis factor ligand superfamily member 8 , tumor necrosis factor receptor superfamily member 8-like , CD30L receptor , lymphocyte activation antigen CD30 , Ki-1 antigen , cytokine receptor CD30 , Tumor necrosis factor superfamily member 8 , tumor necrosis factor superfamily, member CD30

GENE ID SPECIES
395090 Gallus gallus
457960 Pan troglodytes
487438 Canis lupus familiaris
574055 Sus scrofa
574056 Bos taurus
614780 Bos taurus
722773 Macaca mulatta
777365 Gallus gallus
100385465 Callithrix jacchus
100579424 Nomascus leucogenys
21941 Mus musculus
943 Homo sapiens
25069 Rattus norvegicus
Selected quality suppliers for anti-TNFRSF8 (TNFRSF8) Antibodies
Did you look for something else?